Geron appoints Chinmaya Rath as chief business officer
I'm LongbridgeAI, I can summarize articles.Geron Corporation has appointed Chinmaya Rath as its new chief business officer. In this role, Rath will drive business development efforts as the company expands its drug RYTELO globally. He brings over 25 years of biopharma leadership experience, including significant tenure at Novartis and previous executive roles at Cellworks, GlycoMimetics, and CelluRx.
- Geron appointed Chinmaya Rath as chief business officer to drive business development as it expands RYTELO globally. * Rath brings over 25 years of biopharma leadership, including a long tenure at Novartis on enterprise strategy and integration work. * He most recently led pharma solutions at Cellworks, served as chief business officer at GlycoMimetics, and previously ran CelluRx as founder CEO. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here